A large study suggests that buprenorphine has an immediate and lasting effect.
Opioid use disorder (OUD) is an independent risk factor for suicide, a leading cause of mortality in the U.S. Medications for OUD (such as methadone, buprenorphine, and naltrexone) can lessen illicit drug use — and presumably suicide risk. In this retrospective cohort study of more than 60,000 U.S. Veterans Affairs patients with OUD, researchers examined the effect of medications on risk for suicide during a 14-year period (2003–2017).
After adjustment for numerous relevant variables, treatment with OUD medications was associated with ≈50% less risk for suicide mortality. Buprenorphine was associated with a relative risk reduction for suicide mortality of more than 65%. In stark contrast, naltrexone treatment conferred no relative risk reduc…
Reviewing Author
DisclosuresConsultant/Advisory BoardNEJM Healer Advisory Group; Aquifer Clinical Excellence; NBME Clinical Reasoning
Grant/Research SupportSouthern Group on Educational Affairs (SGEA)
Editorial BoardsDiagnosis
Leadership Positions in Professional SocietiesUndergraduate Medical Education (UME) Section Chair, Southern Group on Educational Affairs (SGEA); Chair of Early Career Physicians, American College of Physicians (ACP), Virginia Chapter
DisclosuresConsultant/Advisory BoardNEJM Healer Advisory Group; Aquifer Clinical Excellence; NBME Clinical Reasoning
Grant/Research SupportSouthern Group on Educational Affairs (SGEA)
Editorial BoardsDiagnosis
Leadership Positions in Professional SocietiesUndergraduate Medical Education (UME) Section Chair, Southern Group on Educational Affairs (SGEA); Chair of Early Career Physicians, American College of Physicians (ACP), Virginia Chapter